Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 7/2019

11.04.2019 | Otology

Therapeutic strategies in the treatment of Menière's disease: the Italian experience

verfasst von: Nicola Quaranta, P. Picciotti, G. Porro, B. Sterlicchio, G. Danesi, P. Petrone, Giacinto Asprella Libonati

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Ménière's disease (MD) is an inner ear disorder of unknown etiology, whose pathological substrate is the endolymphatic hydrops. Different treatments have been proposed; however, evidence of their effectiveness is lacking. The aim of this study was to evaluate by a questionnaire which medical and surgical treatments are used in Italy for the treatment of MD and to compare them with those proposed in other countries.

Methods

An electronic questionnaire of 40 questions was formulated and sent to Italian otolaryngologist (ENT) divided into two groups: Group 1 (“generalists” 60.8%) and Group 2 (“neurotologist- NO” 39.2%).

Results

One hundred and twenty five ENT replied. Treatment of the acute phase, apart from symptomatics, was based on diuretics that are prescribed by 83.5% of respondents, steroids, prescribed by 66.7%, and vasodilators, prescribed by 22%. In the intercritical phase, 87.2% of respondents recommended low-salt diet, 78.4% of respondents prescribed betahistine, and 52.8% diuretics. Statistical analysis did not show correlation neither with the declared specialization nor with the number of patients treated. In case of failure of medical treatment, IT gentamicin was suggested by 48.8% of the respondents and IT steroids by 40.8%. Statistical analysis showed that generalists prefer IT steroids and NO IT gentamicin (p 0.019). In case of failure of both medical treatment and IT treatment, vestibular neurectomy was indicated by 58.4% of the respondents, 6.4% indicated endolymphatic sac surgery, and 2.4% surgical labyrinthectomy.

Conclusion

In Italy, the treatment of MD stand on a gradual approach that starts from the dietary-behavioral changes and a pharmacological therapy based on betahistine. In refractory cases, IT treatment initially with steroids and, therefore, with gentamicin allows the control in vertigo in the majority of cases. In case of failure of IT treatment, VNS is the surgery of choice.
Literatur
1.
Zurück zum Zitat Committee on Hearing and Equilibrium (1995) Guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 113:181–185CrossRef Committee on Hearing and Equilibrium (1995) Guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 113:181–185CrossRef
2.
Zurück zum Zitat Tyrrell JS, Whinney DJ, Ukoumunne OC, Fleming LE, Osborne NJ (2014) Prevalence, associated factors, and comorbid conditions for Menière’s disease. Ear Hear 35:e162–e169CrossRef Tyrrell JS, Whinney DJ, Ukoumunne OC, Fleming LE, Osborne NJ (2014) Prevalence, associated factors, and comorbid conditions for Menière’s disease. Ear Hear 35:e162–e169CrossRef
3.
Zurück zum Zitat Harris JP, Alexander TH (2010) Current-day prevalence of Menière’s syndrome. Audiol Neurootol 15:318–322CrossRef Harris JP, Alexander TH (2010) Current-day prevalence of Menière’s syndrome. Audiol Neurootol 15:318–322CrossRef
4.
Zurück zum Zitat Celestino D, Ralli G (1991) Incidence of Ménière’s disease in Italy. Am J Otol 12(2):135–138PubMed Celestino D, Ralli G (1991) Incidence of Ménière’s disease in Italy. Am J Otol 12(2):135–138PubMed
5.
Zurück zum Zitat Minor LB, Schessel DA, Carey JP (2004) Ménière’s disease. Curr Opin Neurol 17(1):9–16CrossRef Minor LB, Schessel DA, Carey JP (2004) Ménière’s disease. Curr Opin Neurol 17(1):9–16CrossRef
6.
Zurück zum Zitat Morrison AW, Jhonson KJ (2002) Genetics (molecular biology) and Ménière's disease. Otolaryngol Clin N Am 35(3):497–516CrossRef Morrison AW, Jhonson KJ (2002) Genetics (molecular biology) and Ménière's disease. Otolaryngol Clin N Am 35(3):497–516CrossRef
7.
Zurück zum Zitat House JW, Doherty JK, Fisher LM, Derebery MJ, Berliner KI (2006) Menière’s disease: prevalence of contralateral ear involvement. Otol Neurotol 27:355–361CrossRef House JW, Doherty JK, Fisher LM, Derebery MJ, Berliner KI (2006) Menière’s disease: prevalence of contralateral ear involvement. Otol Neurotol 27:355–361CrossRef
8.
Zurück zum Zitat Huppert D, Strupp M, Brandt T (2010) Long-term course of Menière’s disease revisited. Acta Otolaryngol 130:644–651CrossRef Huppert D, Strupp M, Brandt T (2010) Long-term course of Menière’s disease revisited. Acta Otolaryngol 130:644–651CrossRef
9.
Zurück zum Zitat Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A, Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology, and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head, and Neck Surgery (AAO-HNS); Korean Balance Society (2015) Diagnostic criteria for Menière's disease. J Vestib Res 25(1):1–7CrossRef Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A, Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology, and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head, and Neck Surgery (AAO-HNS); Korean Balance Society (2015) Diagnostic criteria for Menière's disease. J Vestib Res 25(1):1–7CrossRef
10.
Zurück zum Zitat Goebel JA (2016) 2015 equilibrium Committee amendement to the 1995’s AAO-HNS guidelines for the definition of Menière’s disease. Otolaryngol Head Neck Surg 154(3):403–404CrossRef Goebel JA (2016) 2015 equilibrium Committee amendement to the 1995’s AAO-HNS guidelines for the definition of Menière’s disease. Otolaryngol Head Neck Surg 154(3):403–404CrossRef
11.
Zurück zum Zitat Nakashima T, Pyykkö I, Arroll MA, Casselbrant ML, Foster CA, Manzoor NF, Megerian CA, Naganawa S, Young YH (2016) Menière's disease. Nat Rev Dis Primers 2:16028CrossRef Nakashima T, Pyykkö I, Arroll MA, Casselbrant ML, Foster CA, Manzoor NF, Megerian CA, Naganawa S, Young YH (2016) Menière's disease. Nat Rev Dis Primers 2:16028CrossRef
12.
Zurück zum Zitat Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V (2018) International consensus (ICON) on treatment of Menière’s disease. Euro Ann Otorhinolaryngol Head Neck Dis 135:S29–S32CrossRef Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V (2018) International consensus (ICON) on treatment of Menière’s disease. Euro Ann Otorhinolaryngol Head Neck Dis 135:S29–S32CrossRef
13.
Zurück zum Zitat Smith WK, Sankar V, Pfleiderer AG (2005) A national survey amongst UK otolaryngologists regarding the treatment of Menière’s disease. J Laryngol Otol 119:102–105CrossRef Smith WK, Sankar V, Pfleiderer AG (2005) A national survey amongst UK otolaryngologists regarding the treatment of Menière’s disease. J Laryngol Otol 119:102–105CrossRef
14.
Zurück zum Zitat Clyde JW, Oberman BS, Isildak H (2017) Current Management Practices in Menière's Disease. Otol Neurotol 38:159–167CrossRef Clyde JW, Oberman BS, Isildak H (2017) Current Management Practices in Menière's Disease. Otol Neurotol 38:159–167CrossRef
15.
Zurück zum Zitat Klockhoff I, Lindblom U (1966) Endolymphatic hydrops revealed by glycerol test preliminary report. Acta Otolaryngol. 61(5):459–462CrossRef Klockhoff I, Lindblom U (1966) Endolymphatic hydrops revealed by glycerol test preliminary report. Acta Otolaryngol. 61(5):459–462CrossRef
16.
Zurück zum Zitat Angelborg C, Klockhoff I, Larsen HC, Stahle J (1982) Hyperosmotic solutions and hearing Menière's disease. Am J Otol 3(3):200–202PubMed Angelborg C, Klockhoff I, Larsen HC, Stahle J (1982) Hyperosmotic solutions and hearing Menière's disease. Am J Otol 3(3):200–202PubMed
17.
Zurück zum Zitat Rosenbaum A, Winter M (2018) Are diuretics effective for Ménière`s disease? Medwave 18(2):e7188CrossRef Rosenbaum A, Winter M (2018) Are diuretics effective for Ménière`s disease? Medwave 18(2):e7188CrossRef
18.
Zurück zum Zitat Crowson MG, Patki A, Tucci DL (2016) A systematic review of diuretics in the medical management of Ménière's disease. Otolaryngol Head Neck Surg 154(5):824–834CrossRef Crowson MG, Patki A, Tucci DL (2016) A systematic review of diuretics in the medical management of Ménière's disease. Otolaryngol Head Neck Surg 154(5):824–834CrossRef
19.
Zurück zum Zitat Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M, BEMED Study Group (2016) Efficacy and safety of betahistine treatment in patients with Menière's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 352:6816CrossRef Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M, BEMED Study Group (2016) Efficacy and safety of betahistine treatment in patients with Menière's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 352:6816CrossRef
20.
Zurück zum Zitat Casani AP, Navari E, Guidetti G, Lacour M (2018) Good clinical approach: Delphi Consensus for the use of Betahistine in Menière's disease. Int J Otolaryngol 2018:5359208CrossRef Casani AP, Navari E, Guidetti G, Lacour M (2018) Good clinical approach: Delphi Consensus for the use of Betahistine in Menière's disease. Int J Otolaryngol 2018:5359208CrossRef
21.
Zurück zum Zitat Teggi R, Gatti O, Sykopetrites V, Quaglieri S, Benazzo M, Bussi M (2014) Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine. Acta Otorhinolaryngol Ital 34(5):349–353PubMedPubMedCentral Teggi R, Gatti O, Sykopetrites V, Quaglieri S, Benazzo M, Bussi M (2014) Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine. Acta Otorhinolaryngol Ital 34(5):349–353PubMedPubMedCentral
22.
Zurück zum Zitat Albera R, Ciuffolotti R, Di Cicco M, De Benedittis G, Grazioli I, Melzi G, Mira E, Pallestrini E, Passali D, Serra A, Vicini C (2003) Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 123(5):588–593CrossRef Albera R, Ciuffolotti R, Di Cicco M, De Benedittis G, Grazioli I, Melzi G, Mira E, Pallestrini E, Passali D, Serra A, Vicini C (2003) Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 123(5):588–593CrossRef
23.
Zurück zum Zitat Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R (1991) Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease. Acta Otolaryngol Suppl 490:1–10CrossRef Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R (1991) Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease. Acta Otolaryngol Suppl 490:1–10CrossRef
24.
Zurück zum Zitat Novotný M, Kostrica R (2002) Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J 8(2):115–123PubMed Novotný M, Kostrica R (2002) Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J 8(2):115–123PubMed
25.
Zurück zum Zitat Itoh A, Sakata E (1991) Treatment of vestibular disorders. Acta Otolaryngol Suppl 481:617–623CrossRef Itoh A, Sakata E (1991) Treatment of vestibular disorders. Acta Otolaryngol Suppl 481:617–623CrossRef
26.
Zurück zum Zitat Patel M (2017) Intratympanic corticosteroids in Menière’s disease: a mini-review. J Otol 12:117–124CrossRef Patel M (2017) Intratympanic corticosteroids in Menière’s disease: a mini-review. J Otol 12:117–124CrossRef
27.
Zurück zum Zitat Lange G (1977) The intratympanic treatment of Menière's disease with ototoxic antibiotics A follow-up study of 55 cases (author's transl). Laryngol Rhinol Otol (Stuttg) 56(5):409–414 Lange G (1977) The intratympanic treatment of Menière's disease with ototoxic antibiotics A follow-up study of 55 cases (author's transl). Laryngol Rhinol Otol (Stuttg) 56(5):409–414
28.
Zurück zum Zitat Syed MI, Ilan O, Nassar J, Rutka JA (2015) Intratympanic therapy in Menière's syndrome or disease: up to date evidence for clinical practice. Clin Otolaryngol 40(6):682–690CrossRef Syed MI, Ilan O, Nassar J, Rutka JA (2015) Intratympanic therapy in Menière's syndrome or disease: up to date evidence for clinical practice. Clin Otolaryngol 40(6):682–690CrossRef
29.
Zurück zum Zitat Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I (2001) Intratympanic therapy for Ménière's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 121(3):387–392CrossRef Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I (2001) Intratympanic therapy for Ménière's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 121(3):387–392CrossRef
30.
Zurück zum Zitat Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 25(4):544–552CrossRef Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 25(4):544–552CrossRef
32.
Zurück zum Zitat Sood AJ, Lambert PR, Nguyen SA, Meyer TA (2014) Endolymphatic sac surgery for Ménière's disease: a systematic review and meta-analysis. Otol Neurotol 35(6):1033–1045CrossRef Sood AJ, Lambert PR, Nguyen SA, Meyer TA (2014) Endolymphatic sac surgery for Ménière's disease: a systematic review and meta-analysis. Otol Neurotol 35(6):1033–1045CrossRef
33.
Zurück zum Zitat Quaranta A, Marini F, Sallustio V (1998) Long-term outcome of Ménière's disease: endolymphatic mastoid shunt versus natural history. Audiol Neurootol 3(1):54–60CrossRef Quaranta A, Marini F, Sallustio V (1998) Long-term outcome of Ménière's disease: endolymphatic mastoid shunt versus natural history. Audiol Neurootol 3(1):54–60CrossRef
34.
Zurück zum Zitat Hillman TA, Chen DA, Arriaga MA (2004) Vestibular nerve section versus intratympanic gentamicin for Menière's disease. Laryngoscope 114(2):216–222CrossRef Hillman TA, Chen DA, Arriaga MA (2004) Vestibular nerve section versus intratympanic gentamicin for Menière's disease. Laryngoscope 114(2):216–222CrossRef
Metadaten
Titel
Therapeutic strategies in the treatment of Menière's disease: the Italian experience
verfasst von
Nicola Quaranta
P. Picciotti
G. Porro
B. Sterlicchio
G. Danesi
P. Petrone
Giacinto Asprella Libonati
Publikationsdatum
11.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 7/2019
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-019-05423-7

Weitere Artikel der Ausgabe 7/2019

European Archives of Oto-Rhino-Laryngology 7/2019 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Bilateraler Hörsturz hat eine schlechte Prognose

15.04.2024 Hörsturz Nachrichten

Die Mehrzahl der Menschen mit Hörsturz ist einseitig betroffen, doch auch ein beidseitiger Hörsturz ist möglich. Wie häufig solche Fälle sind und wie sich ihr Verlauf darstellt, hat eine HNO-Expertenrunde aus den USA untersucht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.